Platelet lysate derived macroporous hydrogel loaded with adipose stem cells for spinal cord injury repair.
Wang YF., Huang YQ., Cao HT., Wang Y., Wang JL., Deng JJ.
Animal Study on Spinal Cord Injury, Scar, Chronic Inflammation, published in Biomater Adv (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Animal Study
- Journal
- Biomater Adv (2026)
- Country
- Netherlands
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 41875610
- DOI
- 10.1016/j.bioadv.2026.214815
Abstract (original English)
Spinal cord injury (SCI) can result in irreversible neurological deficits, such as limb paralysis and dysfunctions of urination and defecation. Currently, there remains a dearth of effective therapeutic strategies to fully reverse the detrimental consequences of SCI. Stem cell transplantation, particularly adipose-derived stem cells (ASCs) transplantation, shows great promise in treating SCI. However, the low survival rate of transplanted cells and limited neural differentiation impede its long-term clinical effectiveness. In this study, platelet lysate-rich plasma (PLP) was utilized as the primary matrix component. Through sodium alginate cross-linking, a platelet lysate-rich plasma hydrogel (PLPH) with a micron-scale macroporous structure was fabricated. By precisely modulating the component ratios, PLPH was engineered to possess a low Young's modulus (approximately 1000 Pa), which is comparable to that of spinal cord tissue, along with characteristics such as a low swelling ratio, high porosity, and slow degradation. In vitro, PLPH facilitated the proliferation of ASCs and offered neuroprotection under oxidative stress conditions. Moreover, it promoted axonal growth in neuronal cells. In a mouse model of spinal cord injury, PLPH-loaded ASCs induced M2 polarization of microglia/macrophages at the injury site by activating the signal transducer and activator of transcription 6
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewPubMed
Host immune determinants of stromal vascular fraction graft survival: Toward a concept of SVF therapy resistance - A systematic narrative review.
Systematic Review on Spinal Cord Injury, Chronic Inflammation, Immune Modulation, published in Cell Transplant (2026) — summary generated from the PubMed abstract.
- 2026
Cell Transplant - Level AMeta-analysisPubMed
Stem cell-derived exosome treatment for acute spinal cord injury: a systematic review and meta-analysis based on preclinical evidence.
Meta-analysis on Spinal Cord Injury, published in Front Neurol (2025) — summary generated from the PubMed abstract.
- 2025
Front Neurol - Level ASystematic ReviewPubMed
Brain-derived neurotrophic factor (BDNF) as biomarker in stem cell-based therapies of preclinical spinal cord injury models: A systematic review.
Systematic Review on Spinal Cord Injury, published in Tissue Cell (2025) — summary generated from the PubMed abstract.
- 2025
Tissue Cell3 citations - Level ASystematic ReviewEurope PMC
Revolutionizing neural regeneration with smart responsive materials: Current insights and future prospects
Systematic Review on Spinal Cord Injury, published in Bioact Mater (2025) — summary generated from the PubMed abstract.
- 2025
Bioact Mater5 citations - Level ASystematic ReviewEurope PMC
Conductive Nanocomposite Hydrogels for Neural Tissue Engineering: A Systematic Scoping Review of Recent Trends
Systematic Review with a reported sample of 42 on Diabetic Foot, Stroke Research, Spinal Cord Injury, Neuroinflammation, published in Adv Sci (Weinh) (2025) — summary generated from the PubMed abstract.
- 2025
- n = 42
Adv Sci (Weinh)18 citations - Level ASystematic ReviewEurope PMC
Emerging regenerative strategies for spinal cord injury: exosome-derived mechanisms and therapeutic insights
Systematic Review on Spinal Cord Injury, Neuroinflammation, published in Front Neurosci (2025) — summary generated from the PubMed abstract.
- 2025
Front Neurosci